Vertigo and Motion Sickness. Part II: Pharmacologic Treatment

  title={Vertigo and Motion Sickness. Part II: Pharmacologic Treatment},
  author={Timothy P Zajonc and P. Roland},
  journal={ENT Journal},
  pages={25 - 35}
  • Timothy P Zajonc, P. Roland
  • Published 2006
  • Medicine
  • ENT Journal
  • Vertigo is a sensation of movement when no movement is actually occurring. It is often accompanied by visceral autonomic symptoms including pallor, diaphoresis, nausea, and vomiting. Vertigo is similar to motion sickness in that both may be caused by vestibular stimulation that does not match an internal model of expected environmental stimuli. Indeed, a functioning vestibular system is necessary for the perception of motion sickness. For this reason, many of the same drugs are used to treat… CONTINUE READING
    35 Citations

    Tables and Topics from this paper

    Prevention and treatment of motion sickness.
    • 43
    • PDF
    Principles of vestibular pharmacotherapy.
    • 12
    Verification of Motion Sickness Index in Mice
    • 6
    Neuropharmacology of Vestibular System Disorders
    • 63
    • PDF
    Vestibular evoked myogenic potentials and habituation to seasickness
    • 15
    Neuropharmacological basis of vestibular system disorder treatment.
    • 16


    Diazepam as an anti-motion sickness drug.
    • 27
    Flunarizine in the Treatment of Vestibular Vertigo: Experimental and Clinical Data
    • 17
    Calcium antagonists in the prevention of motion sickness.
    • 30
    Physiological basis and pharmacology of motion sickness: an update
    • 201
    Use of Promethazine to Hasten Adaptation to Provocative Motion
    • 33
    Vertigo and Motion Sickness. Part I: Vestibular Anatomy and Physiology
    • 23
    • PDF
    Use of phenytoin in the prevention of motion sickness.
    • 12